• Careers
  • Contact Us
Pharma & Life Sciences

Pharma & Life Sciences

Articles & Blogs Pharma & Life Sciences

Why You Need to Be Careful When Agreeing Example Calculations in Your Contracts

Wednesday, 06 September 2017

The Court of Appeal has concluded that example calculations in a contract were legally binding and not simply illustrative.

Why You Need to Be Careful When Agreeing Example Calculations in Your Contracts

Brexit Articles & Blogs Pharma & Life Sciences

Brexit: Positive Noises on Regulatory Cooperation in Pharma & Life Sciences Sector

Wednesday, 09 August 2017

We recently reported that organisations from across the pharma and healthcare spectrum had joined forces to create the Brexit Health Alliance with the aim of safeguarding issues of health in light of Britain leaving the European Union.


Articles & Blogs Pharma & Life Sciences

Pharmacy Organisations Given Permission to Appeal High Court Decision on Cuts to Community Pharmacy Budget

Wednesday, 09 August 2017

The Pharmaceutical Services Negotiating Committee (PSNC) and the National Pharmacy Association (NPA) have both been given permission to lodge an appeal against the High Court decision which found the planned budget cuts for community pharmacy legal.

Pharmacy Organisations Given Permission to Appeal High Court Decision on Cuts to Community Pharmacy Budget

Articles & Blogs Pharma & Life Sciences

New Legislation Around Medical Devices - How this Could Affect Manufacturers and the Supply Chain

Wednesday, 09 August 2017

There are more than 500,000 types of medical devices and in vitro diagnostic devices on the EU market ranging from sticking plasters and scalpels to pacemakers and breast implants...

New Legislation Around Medical Devices - How this Could Affect Manufacturers and the Supply Chain

Articles & Blogs Pharma & Life Sciences

Routine DNA Tests on the NHS - Will Precision Medicine Help or Hinder Your Organisation?

Wednesday, 09 August 2017

England's Chief Medical Officer, Dame Sally Davies, announced recently that genomic testing should be made routine on the NHS in order to provide patients with more personalised treatment plans through the establishment of a National Genomics Board.

Routine DNA Tests on the NHS - Will Precision Medicine Help or Hinder Your Organisation?

Brexit Articles & Blogs Pharma & Life Sciences

Pharma and Healthcare Bodies Join Forces to Put Forward Co-Operative Voice on Brexit Issues

Wednesday, 19 July 2017

Organisations from across the pharma and healthcare spectrum have joined forces to create the Brexit Health Alliance (BHA).


Articles & Blogs Pharma & Life Sciences

Could Aspirin Be Making People's Conditions Worse Rather than Better?

Wednesday, 19 July 2017

Millions of elderly people take aspirins every day to reduce risks of heart attack and stroke.

Could Aspirin Be Making People's Conditions Worse Rather than Better?

Articles & Blogs Pharma & Life Sciences

Report Warns of Mistrust Towards Pharmaceuticals Both by Clinicians and Patients

Wednesday, 19 July 2017

A majority of GPs considers clinical trials to be biased in order to produce a positive outcome, claims a report released by the Academy of Medical Sciences.

Report Warns of Mistrust Towards Pharmaceuticals Both by Clinicians and Patients

Articles & Blogs Pharma & Life Sciences

Modified Antibiotic Signifies Hope Against Deadly Superbugs - Why it Pays to Keep Innovating

Wednesday, 19 July 2017

A study by The Scripps Research Institute (TSRI) in California has found that a modified form of the antibiotic 'vancomycin' is a thousand times stronger than the previous version of the drug.

Modified Antibiotic Signifies Hope Against Deadly Superbugs - Why it Pays to Keep Innovating

Articles & Blogs Pharma & Life Sciences

Scheme Criticised for Using Incentives for GPs to Reduce Money on Medicines - the Potential Impact on Patients

Wednesday, 21 June 2017

GPs in Oxfordshire have been incentivised to reduce the amount of medicines being prescribed to the elderly in care homes, according to Pulse magazine.

Scheme Criticised for Using Incentives for GPs to Reduce Money on Medicines - the Potential Impact on Patients

Articles & Blogs Pharma & Life Sciences

Confidence for Generics Companies After Dominant Company Accused of Unlawful Tactics

Wednesday, 21 June 2017

The Competition and Markets Authority has decided to take action against MSD, the big pharma company, for alleged abuse of dominant position in the market, contrary to Chapter II of the Competition Act.

Confidence for Generics Companies After Dominant Company Accused of Unlawful Tactics

Articles & Blogs Pharma & Life Sciences

Contractual Intention and Confusing Clauses - Interpreting Unclear Contracts

Wednesday, 21 June 2017

When there is uncertainty over meaning within a contract, the Supreme Court in the 2015 case of Arnold v Britton established that the court ascertains the parties' intentions by reference to what a reasonable person having all the background knowledge...

Contractual Intention and Confusing Clauses - Interpreting Unclear Contracts

Articles & Blogs Pharma & Life Sciences

"Who's Calling Please?" - Record Fine Issued to Company Following 99.5 Million Nuisance Calls

Wednesday, 21 June 2017

The Information Commissioner's Office (ICO) has issued a record fine of £400,000 to Keurboom Communications Ltd for making 99.5 million nuisance calls over an 18 month period. The fine is the largest yet to be issued by the ICO for nuisance calls.


Articles & Blogs Pharma & Life Sciences

Court Gives Effect to Arbitration Clause to Sort out Amendments Are Changes from Original Position

Thursday, 25 May 2017

Parties to commercial contracts sometimes provide for changes if a future event happens. They may not know how to change the contract, but want to provide that they will agree and if they cannot agree then for someone else to make a decision for them.

Court Gives Effect to Arbitration Clause to Sort out Amendments Are Changes from Original Position

Articles & Blogs Pharma & Life Sciences

Antidepressant and Cancer Drugs Could Be First to Halt Dementia

Thursday, 25 May 2017

A common anti-depressant drug could be the first drug to halt dementia in its tracks.

Antidepressant and Cancer Drugs Could Be First to Halt Dementia